Gli altri portali
Notizie
Comunicati Stampa
Social News
Offerte di Lavoro
Comunicati Stampa
Sezioni
Toggle navigation
Prima pagina
Elenco
Nuovo account
Inserimento
Pannello di controllo
Modifica password
Salute e Benessere
Seleziona Categoria
Tutte le Categorie
Agricoltura
Ambiente
Arte e Cultura
Cibi e Bevande
Economia
Editoria e Media
Elettronica
Energia
Fiere ed Eventi
Industria
Information Technology
Internet
Istruzione e Formazione
Moda
Non Profit
Politica e Istituzioni
Salute e Benessere
Scienza e Tecnologia
Servizi
Società
Spettacolo
Sport
Telecomunicazioni
Trasporti
Turismo
Varie
Italiano
Inglese
Spagnolo
MolecuLight Awarded Federal Supply Contract for the US Department of Veterans…
"VA patients suffer from all types of wounds, including traumatic, diabetic foot and venous leg ulcers, burns and surgical site infections, to name a few, and they deserve the best treatment to help diagnose and treat their ailments, and improve their quality of life," says Anil Amlani, MolecuLight's CEO. "The MolecuLight suite of devices is the only Class ll FDA-cleared point-of-care platform enabling clinicians to detect harmful bacteria that is linked to infection and prevents…
PR Newswire
25/01/2024
BioSenic presents new Phase 3 data on JTA-004 to treat severe osteoarthritis…
PRESS RELEASE BioSenic presents new Phase 3 data on JTA-004 to treat severe osteoarthritis pain at the 2024 OARSI World CongressUsing a recently published approach to stratify patients with knee osteoarthritis, an external post hoc analysis of Phase 3 data showed JTA-004 is safe and efficient for treating pain symptoms in the most severely affected patients.Mont-Saint-Guibert, Belgium, January 25 2024, 7.00 am CET –BioSenic(Euronext Brussels and Paris: BIOS),the...
Nasdaq GlobeNewswire
25/01/2024
Transthyretin Amyloidosis Market is Predicted to Exhibit Remarkable Growth by…
Key Takeaways from the Transthyretin Amyloidosis Market Report Key Takeaways from the Transthyretin Amyloidosis Market Report Discover which therapies are expected to grab the major ATTR market share @Transthyretin Amyloidosis Market Report Transthyretin Amyloidosis Overview Transthyretin Amyloidosis (ATTR) is an rare genetic disorder marked by the accumulation of abnormal amyloid protein deposits, categorized into two primary types: hereditary ATTR (hATTR) and wild-type ATTR (wtATTR)...
PR Newswire
24/01/2024
Minimally Invasive Procedures Pump Up Electrophysiology Market to $9 Trillion by…
Request Exclusive Sample Report: Electrophysiology Industry Strategic Insights, https://www.futuremarketinsights.com/reports/sample/rep-gb-12402 Request Exclusive Sample Report: Electrophysiology Industry Strategic Insights,https://www.futuremarketinsights.com/reports/sample/rep-gb-12402 The demand for cardiac ablation procedures is increasing across various geographies. Thus, spurring the adoption of electrophysiology devices and equipment. Certain common factors that drive...
PR Newswire
24/01/2024
3D Bio-Printing Industry to Surpass a Valuation of US$ 6.82 billion By 2034…
Request Exclusive Sample Report: 3D Bio-Printing Industry Strategic Insights, https://www.futuremarketinsights.com/reports/sample/rep-gb-808 Request Exclusive Sample Report: 3D Bio-Printing Industry Strategic Insights,https://www.futuremarketinsights.com/reports/sample/rep-gb-808 The field of 3D printing has witnessed a continuous improvement in biocompatible materials, particularly biomimetic materials, designed to mimic natural tissues' properties, such as their elasticity...
PR Newswire
24/01/2024
Drug-Eluting Balloons Global Market is Expected to Expand at a Healthy Growth…
Key Takeaways from the Drug-Eluting Balloons Market Report Key Takeaways from the Drug-Eluting Balloons Market Report To read more about the latest highlights related to the drug-eluting balloons market, get a snapshot of the key highlights entailed in theGlobal Drug-Eluting Balloons Market Report Drug-Eluting Balloons Overview Drug-eluting balloons (DEBs) represent a groundbreaking advancement in the field of interventional cardiology and vascular medicine. These...
PR Newswire
24/01/2024
Half-Year Review of Inventiva's Liquidity Contract with Kepler Cheuvreux
Daix (France), Long Island City (New York, United States), January 24, 2024– Inventiva (Euronext Paris and Nasdaq: IVA) (the “Company”), a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of patients with non-alcoholic steatohepatitis (“NASH”) and other diseases with significant unmet medical needs, today announced the half-year report of its liquidity contract with Kepler Cheuvreux. Under the liquidity contract...
Nasdaq GlobeNewswire
24/01/2024
icotec ag raises $30m in growth financing from MVM Partners
"We are thrilled to partner with MVM, whose deep understanding of the healthcare landscape aligns seamlessly with our vision for the future," said Roger Stadler, Group CEO of icotec ag. "This partnership marks a pivotal moment for icotec, supporting us to advance our mission of improving patient outcomes by offering a convincing alternative to the 100-year-old material technology of metal implants." "We are thrilled to partner with MVM, whose deep understanding of the…
PR Newswire
24/01/2024
Transparency Notifications from Shareholders
PRESS RELEASE REGULATED INFORMATION24 January 2024, 06:00 pm CETGhent, Belgium – 24 January 2024 – Sequana Medical NV (Euronext Brussels: SEQUA)(the " Company " or " SequanaMedical "), a pioneer in the treatment of fluid overload in liver disease, heart failure and cancer, announces today that it received transparency notifications from the shareholders listed below, notifying the number of voting rights attached to shares mentioned next to their respective names in the table…
Nasdaq GlobeNewswire
24/01/2024
First Cannabis full-spectrum product, manufactured in Brazil by Ease Labs, is…
"It is the first product containing THC manufactured in Brazil approved by Anvisa, which will help patients with different diseases. The approval was possible because of our strict safety and quality standards, our team's outstanding technical expertise and our agility," explains Gustavo Palhares, Ease Labs CEO and co-founder. According to him, until now, patients were relying exclusively on imported products that are sold at much higher prices. "It is the first product containing…
PR Newswire
24/01/2024
Molecular Cytogenetics Market Worth $4.9 Billion | MarketsandMarkets™
Browse in-depth TOC on "Molecular Cytogenetics Market" Browse in-depth TOC on "Molecular Cytogenetics Market" 139 - Tables 45 - Figures 240 - Pages Molecular Cytogenetics Market Scope: In 2022, the kits & reagents segment held the largest share of the molecular cytogenetics market by product segment. The molecular cytogenetics market is segmented into kits & reagents, instruments, consumables and software & services based on products. The kits &...
PR Newswire
24/01/2024
AIM ImmunoTech Receives Erasmus Medical Center Ethics Board Authorization for…
Subject enrollment is expected in Q1 2024 AIM ImmunoTech Inc.(NYSE American: AIM) (“AIM” or the “Company”) today announced that it has received authorization from the Erasmus Medical Center (“Erasmus MC”) Ethics Committee to open a European site for the ongoing Phase 2 study (“AMP-270”) of Ampligen as a therapy for locally advanced pancreatic cancer. “Approval from the governing ethics board is an important step toward enrolling subjects in the European arm of the AMP-270 clinical...
Nasdaq GlobeNewswire
24/01/2024
How Psychedelic-Based Therapeutics Are Advancing in Treating Generalized Anxiety…
It continued: "DelveInsight's analyst projects that among the total diagnosed prevalent cases of Generalized Anxiety Disorder (GAD) in 7MM approximately 53% of cases were from the US. As per our estimations, in 2022, the EU4 and the UK accounted for nearly 6,007,995 diagnosed prevalent cases of GAD. In the 7MM, the market mainly consisted of standard treatments like SSRIs/SNRIs, Benzodiazepines, Tricyclic Antidepressants/Azapirone (Buspirone), and others (Antiepileptics, antipsychotics…
PR Newswire
24/01/2024
WestGene Spearheads Oncology Breakthroughs at the 3rd mRNA-Based Therapeutics…
In her keynote, Dr. Song discussed updates and interim data on mRNA-based cancer vaccines targeting EBV-associated cancers and HBV positive liver cancer. She discussed WestGene's breakthroughs in the treatment of specific cancers such as nasopharyngeal carcinoma, NKT lymphoma, HBV-related hepatocellular carcinoma and colorectal cancer, highlighting the safety and efficacy established by the IIT clinical trial data. This speech underscored the transformative impact of WestGene's mRNA therapy in…
PR Newswire
24/01/2024
Evaxion to Develop Tailored Novel Cancer Vaccines Based upon a New Untapped…
Tailored Vaccines:With the AI-Immunology™ enabled discovery of these novel types of cancer vaccine targets, designing personalized and precision vaccine solutions becomes feasible and highly promising for patients in need Transformative Vaccine Concept:This AI-Immunology™ powered vaccine concept offers the potential to provide treatment solutions to cancer patients who are usually unresponsive to cancer immunotherapy COPENHAGEN, Denmark, Jan.24, 2024(GLOBE NEWSWIRE) -- Evaxion...
Nasdaq GlobeNewswire
24/01/2024
Groupe Casino: Group Casino announces that it has reached agreements with Auchan…
Group Casino announces that it has reached agreements with Auchan Retail and Groupement Les Mousquetaires for the sale of Casino hypermarkets and supermarkets Paris, 24 January 2024At the end of the exclusive negotiations initiated on December 18, 2023 1, concerning the sale by the Group Casino of almost all of its hypermarkets and supermarkets 2, the Group Casino announces that it has reached agreements with Auchan Retail France* and Groupement Les Mousquetaires**.These agreements...
Nasdaq GlobeNewswire
24/01/2024
Sirius Medical Celebrates the Enrollment of the First Patient in the MELODY…
Leading the MELODY study is Prof. Dr. Maggie Banys-Paluchowski, leader of the Comprehensive Breast Cancer Center of the Universitätsklinikum Schleswig-Holstein Campus Lübeck from the University of Lubeck (Germany). Leading the MELODY study is Prof. Dr.Maggie Banys-Paluchowski, leader of the Comprehensive Breast Cancer Center of the Universitätsklinikum Schleswig-Holstein Campus Lübeck from the University of Lubeck ( Germany ). "As a specialized oncoplastic breast surgeon and the...
PR Newswire
24/01/2024
Endo Announces Publication of New XIAFLEX® (collagenase clostridium…
"Healthcare providers and patients can choose among multiple surgical and nonsurgical treatment options for Dupuytren's disease, and without established guidelines, the process for sorting through those choices can be overwhelming," said Dr. Gary M. Pess, a hand and upper extremity surgeon and lead author of the study. "This study provides insight from experienced hand surgeons about using XIAFLEX to treat varying degrees of Dupuytren's contracture." "Healthcare…
PR Newswire
24/01/2024
Seegene Announces Collaboration with Microsoft to Realize 'a World Free from All…
To realize such a goal, Seegene will work with Microsoft's global healthcare team to help further SG OneSystemTM's growth by advocating the collective vision, bridging potential partners, and jointly participating in SG OneSystemTM's annual symposium. Other key events connecting current and prospective SG OneSystemTM partners, such as a declaration ceremony for scientific communities and other partners participating in the SG OneSystemTM business will be held within the first half of this year…
PR Newswire
24/01/2024
KFSH&RC Celebrates 25 Scientists Named in Stanford's Top 2% Most-Cited…
RIYADH, Saudi Arabia, Jan.24, 2024(GLOBE NEWSWIRE) -- King Faisal Specialist Hospital and Research Centre honored 25 scientists who joined Stanford University's prestigious list, marking them among the 'top 2% most-cited scientists' list updated in October 2023.The recent release recognizes 25 distinguished KFSH&RC scientists, among the top 2% most-cited researchers worldwide in 2021-2022, and acknowledges their overall career accomplishments. This prestigious recognition...
Nasdaq GlobeNewswire
24/01/2024
SHL Medical partners with SteriPack Group to set up final assembly service
Recognizing the importance of flexibility and time-to-market, especially in clinical production, the partnership with SteriPack will offer SHL Medical's customers highly flexible and personalized final assembly and packaging solutions. This is particularly beneficial for small batch handling in clinical supply and niche markets like rare diseases. Emphasizing the comprehensive capabilities of the Molly platform, SHL Medical aims to deliver right-sized solutions that ensure improved service…
PR Newswire
24/01/2024
Invitation: Sobi's Q4 and FY 2023 report
Investors, analysts, and media are invited to participate in a conference call, which will include a presentation of the results and a Q&A session on the same day at 14:00 CET, 13:00 pm GMT, and 8:00 am EDT. Investors, analysts, and media are invited to participate in a conference call, which will include a presentation of the results and a Q&A session on the same day at 14:00 CET,13:00 pm GMT, and8:00 am EDT. The presentation can be followed livehere or afterwards onsobi...
PR Newswire
24/01/2024
Coloplast Finance B.V. - Change of Auditor
Attachment 02_2024_Change_of_Auditor_Coloplast_Finance_B.V.
Nasdaq GlobeNewswire
24/01/2024
Coloplast Finance B.V. - Decisions at the Annual General Meeting
On 24 January 2024, Coloplast Finance B.V. held its Annual General Meeting. At the Annual General Meeting, the sole shareholder, Coloplast A/S, approved the annual report for the financial year 2022/23. In addition, Ernst & Young Accountants LLP was appointed as auditor for Coloplast Finance B.V. Attachment 01_2024_Decisions_at_the_Annual_General_Meeting_Coloplast_Finance_B.V.
Nasdaq GlobeNewswire
24/01/2024
Altri Comunicati
